BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23345574)

  • 1. Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age.
    Byrnes CA; Vidmar S; Cheney JL; Carlin JB; Armstrong DS; Cooper PJ; Grimwood K; Moodie M; Robertson CF; Rosenfeld M; Tiddens HA; Wainwright CE;
    Thorax; 2013 Jul; 68(7):643-51. PubMed ID: 23345574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.
    Wainwright CE; Vidmar S; Armstrong DS; Byrnes CA; Carlin JB; Cheney J; Cooper PJ; Grimwood K; Moodie M; Robertson CF; Tiddens HA;
    JAMA; 2011 Jul; 306(2):163-71. PubMed ID: 21750293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
    Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
    Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchiectases at early chest computed tomography in children with cystic fibrosis are associated with increased risk of subsequent pulmonary exacerbations and chronic pseudomonas infection.
    Bortoluzzi CF; Volpi S; D'Orazio C; Tiddens HA; Loeve M; Tridello G; Assael BM
    J Cyst Fibros; 2014 Sep; 13(5):564-71. PubMed ID: 24726420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative chest computerized tomography and FEV
    Sanders DB; Li Z; Parker-McGill K; Farrell P; Brody AS
    Pediatr Pulmonol; 2018 Oct; 53(10):1369-1377. PubMed ID: 30160050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
    Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
    BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis.
    Ramsey KA; Ranganathan S; Park J; Skoric B; Adams AM; Simpson SJ; Robins-Browne RM; Franklin PJ; de Klerk NH; Sly PD; Stick SM; Hall GL;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1111-6. PubMed ID: 25321321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chest computed tomography predicts the frequency of pulmonary exacerbations in children with cystic fibrosis.
    Sanders DB; Li Z; Brody AS
    Ann Am Thorac Soc; 2015 Jan; 12(1):64-9. PubMed ID: 25474182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Rosenfeld M; Rayner O; Smyth AR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD001912. PubMed ID: 32997797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Course of Illness after Viral Infection in Indian Children with Cystic Fibrosis.
    Gulla KM; Balaji A; Mukherjee A; Jat KR; Sankar J; Lodha R; Kabra SK
    J Trop Pediatr; 2019 Apr; 65(2):176-182. PubMed ID: 29893951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis.
    Loeve M; Gerbrands K; Hop WC; Rosenfeld M; Hartmann IC; Tiddens HA
    Chest; 2011 Jul; 140(1):178-185. PubMed ID: 21148242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.
    Main E; Rand S
    Cochrane Database Syst Rev; 2023 May; 5(5):CD002011. PubMed ID: 37144842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright C; Smyth AR
    Cochrane Database Syst Rev; 2016 Jan; (1):CD009530. PubMed ID: 26797965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright C; Smyth AR
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial.
    Stick SM; Foti A; Ware RS; Tiddens HAWM; Clements BS; Armstrong DS; Selvadurai H; Tai A; Cooper PJ; Byrnes CA; Belessis Y; Wainwright C; Jaffe A; Robinson P; Saiman L; Sly PD;
    Lancet Respir Med; 2022 Aug; 10(8):776-784. PubMed ID: 35662406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis.
    Stahl M; Wielpütz MO; Graeber SY; Joachim C; Sommerburg O; Kauczor HU; Puderbach M; Eichinger M; Mall MA
    Am J Respir Crit Care Med; 2017 Feb; 195(3):349-359. PubMed ID: 27575911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT.
    Mott LS; Park J; Murray CP; Gangell CL; de Klerk NH; Robinson PJ; Robertson CF; Ranganathan SC; Sly PD; Stick SM;
    Thorax; 2012 Jun; 67(6):509-16. PubMed ID: 22201161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis.
    Farrell PM; Li Z; Kosorok MR; Laxova A; Green CG; Collins J; Lai HC; Makholm LM; Rock MJ; Splaingard ML
    Pediatr Pulmonol; 2003 Sep; 36(3):230-40. PubMed ID: 12910585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucus plugging, air trapping, and bronchiectasis are important outcome measures in assessing progressive childhood cystic fibrosis lung disease.
    Robinson TE; Goris ML; Moss RB; Tian L; Kan P; Yilma M; McCoy KS; Newman B; de Jong PA; Long FR; Brody AS; Behrje R; Yates DP; Cornfield DN
    Pediatr Pulmonol; 2020 Apr; 55(4):929-938. PubMed ID: 31962004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.